Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc.
Listing Exchange:
CSEStatus:
ActiveIndustry:
Life SciencesSymbol:
MYCOAssociated Securities:
Mydecine Innovations Group Inc. 12FEB2024 WarrantsCSE Index:
Currency:
Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.
Mydecine Innovations Group Inc. (MYCO)
SEDAR Information
Company Info
Address
789 W Pender Street, Suite 810
Vancouver, BC V6C 1H2
CanadaPhone
604-687-2038Email
contact@mydecineinc.comWebsite
http://www.mydecineinc.comListing date
Monday, August 18, 2014Transfer Agent
National Securities Administrators Ltd.Investor Relations
D. Joshua BartchEmail
contact@mydecineinc.comAuditor
Adam Sung Kim Ltd.Capitalization
Issued & Outstanding:
227,275,407Reserved for Issuance:
52,748,136News Releases
Bulletins
12/02/2021
2021-0228 – New Listing - Mydecine Innovations Group Inc. Warrants (MYCO.WT)
Le 12 février/February 2021
Mydecine Innovations Group Inc. Warrants (the "Warrants") have been approved for listing.
Each Warrant shall, entitle the holder thereof to acquire one (1) Common Share after the Issue Date and prior to the Expiry Time, upon payment of the Exercise Price of $0.70.
See the Warrant Indenture for full details.
_____________________
Les bons de souscription de Mydecine Innovations Group Inc. (les «bons de souscription») ont été approuvés pour inscription.
Advertisement
Publicité